Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High Content & Phenotypic Screening 2017

Leo Price's Biography



Leo Price, CEO, Ocello B.V

Leo Price was trained as a cell biologist and has held positions in London, San Diego, Amsterdam and Utrecht in cancer research. From 2005, he ran a research group at Leiden University, where he developed 3D tissue culture based screening technology. This technology was spun off as OcellO, a contract research company that develops physiologically relevant models of disease and uses these to offer compound screening and profiling services for the drug discovery industry.

Leo Price Image

Screening and Profiling of Cancer Therapeutics in Primary and Stem Cell-derived Human 3D Tissues

Wednesday, 26 April 2017 at 14:30

Add to Calendar ▼2017-04-26 14:30:002017-04-26 15:30:00Europe/LondonScreening and Profiling of Cancer Therapeutics in Primary and Stem Cell-derived Human 3D TissuesHigh Content and Phenotypic Screening 2017 in Holiday Inn, Cambridge, UKHoliday Inn, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com

This lecture will give an overview of OcellO’s screening methodology and its application to drug discovery for various cancers.


Add to Calendar ▼2017-04-25 00:00:002017-04-26 00:00:00Europe/LondonHigh Content and Phenotypic Screening 2017High Content and Phenotypic Screening 2017 in Holiday Inn, Cambridge, UKHoliday Inn, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com